Kaplon H, Reichert JM (2019) Antibodies to watch in 2019. MAbs 11:219–238. https://doi.org/10.1080/19420862.2018.1556465
Article CAS PubMed Google Scholar
Kaplon H, Muralidharan M, Schneider Z, Reichert JM (2020) Antibodies to watch in 2020. MAbs 12:1703531. https://doi.org/10.1080/19420862.2019.1703531
Article CAS PubMed Google Scholar
Chames P, Van Regenmortel M, Weiss E, Baty D (2009) Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 157:220–233. https://doi.org/10.1111/j.1476-5381.2009.00190.x
Article CAS PubMed PubMed Central Google Scholar
Warszawski S, Katz AB, Lipsh R et al (2019) Optimizing antibody affinity and stability by the automated design of the variable light–heavy chain interfaces. PLoS Comput Biol 15:e1007207. https://doi.org/10.1371/journal.pcbi.1007207
Article CAS PubMed PubMed Central Google Scholar
Raybould MIJ, Marks C, Krawczyk K et al (2019) Five computational developability guidelines for therapeutic antibody profiling. Proc Natl Acad Sci USA 116:4025–4030. https://doi.org/10.1073/pnas.1810576116
Article CAS PubMed PubMed Central Google Scholar
Le Basle Y, Chennell P, Tokhadze N et al (2020) Physicochemical stability of monoclonal antibodies: a review. J Pharm Sci 109:169–190. https://doi.org/10.1016/j.xphs.2019.08.009
Article CAS PubMed Google Scholar
Yang X, Xu W, Dukleska S et al (2013) Developability studies before initiation of process development. MAbs 5:787–794. https://doi.org/10.4161/mabs.25269
Article PubMed PubMed Central Google Scholar
Cromwell MEM, Hilario E, Jacobson F (2006) Protein aggregation and bioprocessing. AAPS J 8:E572–E579. https://doi.org/10.1208/aapsj080366
Article CAS PubMed PubMed Central Google Scholar
Acierno JP, Braden BC, Klinke S et al (2007) Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies. J Mol Biol 374:130–146. https://doi.org/10.1016/j.jmb.2007.09.005
Article CAS PubMed Google Scholar
Fernández-Quintero ML, Loeffler JR, Bacher LM et al (2020) Local and global rigidification upon antibody affinity maturation. Front Mol Biosci 7:182. https://doi.org/10.3389/fmolb.2020.00182
Article CAS PubMed PubMed Central Google Scholar
Cauerhff A, Goldbaum FA, Braden BC (2004) Structural mechanism for affinity maturation of an anti-lysozyme antibody. Proc Natl Acad Sci USA 101:3539–3544. https://doi.org/10.1073/pnas.0400060101
Article CAS PubMed PubMed Central Google Scholar
Julian MC, Li L, Garde S et al (2017) Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability. Sci Rep 7:45259. https://doi.org/10.1038/srep45259
Article CAS PubMed PubMed Central Google Scholar
Davies DR, Chacko S (1993) Antibody structure. Acc Chem Res 26:421–427. https://doi.org/10.1021/ar00032a005
Nowak J, Baker T, Georges G et al (2016) Length-independent structural similarities enrich the antibody CDR canonical class model. MAbs 8:751–760. https://doi.org/10.1080/19420862.2016.1158370
Article CAS PubMed PubMed Central Google Scholar
Stanfield RL, Takimoto-Kamimura M, Rini JM et al (1993) (1993) Major antigen-induced domain rearrangements in an antibody. Structure (Lond Engl) 1:83–93. https://doi.org/10.1016/0969-2126(93)90024-b
Fernández-Quintero ML, Pomarici ND, Math BA et al (2020) Antibodies exhibit multiple paratope states influencing VH–VL domain orientations. Commun Biol 3:1–14. https://doi.org/10.1038/s42003-020-01319-z
Banfield MJ, King DJ, Mountain A, Brady RL (1997) VL:VH domain rotations in engineered antibodies: crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs. Proteins Struct Funct Bioinform 29:161–171. https://doi.org/10.1002/(SICI)1097-0134(199710)29:2%3c161::AID-PROT4%3e3.0.CO;2-G
Kuroda D, Tsumoto K (2018) Antibody affinity maturation by computational design. Methods Mol Biol (Clifton NJ) 1827:15–34. https://doi.org/10.1007/978-1-4939-8648-4_2
Joshi KK, Phung W, Han G et al (2019) Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells. MAbs 11:1254–1265. https://doi.org/10.1080/19420862.2019.1640549
Article CAS PubMed PubMed Central Google Scholar
Fernández-Quintero ML, Kroell KB, Grunewald LJ et al (2022) CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies. MAbs 14:2024118. https://doi.org/10.1080/19420862.2021.2024118
Article CAS PubMed PubMed Central Google Scholar
Billings KS, Best RB, Rutherford TJ, Clarke J (2008) Crosstalk between the protein surface and hydrophobic core in a core-swapped fibronectin type III domain. J Mol Biol 375:560–571. https://doi.org/10.1016/j.jmb.2007.10.056
Article CAS PubMed PubMed Central Google Scholar
Kuroda D, Tsumoto K (2020) Engineering stability, viscosity, and immunogenicity of antibodies by computational design. J Pharm Sci 109:1631–1651. https://doi.org/10.1016/j.xphs.2020.01.011
Article CAS PubMed Google Scholar
Chang H-J, Jian J-W, Hsu H-J et al (2014) Loop-sequence features and stability determinants in antibody variable domains by high-throughput experiments. Structure 22:9–21. https://doi.org/10.1016/j.str.2013.10.005
Article CAS PubMed Google Scholar
Röthlisberger D, Honegger A, Plückthun A (2005) Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. J Mol Biol 347:773–789. https://doi.org/10.1016/j.jmb.2005.01.053
Article CAS PubMed Google Scholar
Adachi M, Kurihara Y, Nojima H et al (2003) Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL–HyHEL-10 complex. Protein Sci Publ Protein Soc 12:2125–2131
Labrijn AF, Janmaat ML, Reichert JM, Parren PWHI (2019) Bispecific antibodies: a mechanistic review of the pipeline. Nat Rev Drug Discov 18:585–608. https://doi.org/10.1038/s41573-019-0028-1
Article CAS PubMed Google Scholar
Ma J, Mo Y, Tang M et al (2021) Bispecific antibodies: from research to clinical application. Front Immunol 12:1555. https://doi.org/10.3389/fimmu.2021.626616
Ridgway JB, Presta LG, Carter P (1996) “Knobs-into-holes” engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng 9:617–621. https://doi.org/10.1093/protein/9.7.617
Article CAS PubMed Google Scholar
De Nardis C, Hendriks LJA, Poirier E et al (2017) A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1. J Biol Chem 292:14706–14717. https://doi.org/10.1074/jbc.M117.793497
Article PubMed PubMed Central Google Scholar
Leaver-Fay A, Froning KJ, Atwell S et al (1993) (2016) Computationally designed bispecific antibodies using negative state repertoires. Structure (Lond Engl) 24:641–651. https://doi.org/10.1016/j.str.2016.02.013
Bönisch M, Sellmann C, Maresch D et al (2017) Novel CH1:CL interfaces that enhance correct light chain pairing in heterodimeric bispecific antibodies. Protein Eng Des Sel 30:685–696. https://doi.org/10.1093/protein/gzx044
Article CAS PubMed PubMed Central Google Scholar
Teplyakov A, Obmolova G, Malia TJ et al (2016) Structural diversity in a human antibody germline library. MAbs 8:1045–1063. https://doi.org/10.1080/19420862.2016.1190060
Article CAS PubMed PubMed Central Google Scholar
de Wildt RM, Hoet RM, van Venrooij WJ et al (1999) Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 285:895–901. https://doi.org/10.1006/jmbi.1998.2396
Berman HM, Westbrook J, Feng Z et al (2000) The Protein Data Bank. Nucleic Acids Res 28:235–242. https://doi.org/10.1093/nar/28.1.235
Article CAS PubMed PubMed Central Google Scholar
Molecular Operating Environment (MOE) | MOEsaic | PSILO. https://www.chemcomp.com/Products.htm. Accessed 3 Nov 2020
Labute P (2009) Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures. Proteins 75:187–205. https://doi.org/10.1002/prot.22234
留言 (0)